Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Toshiba Corporation
  6. News
  7. Summary
    6502   JP3592200004

TOSHIBA CORPORATION

(6502)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Toshiba : Commencement of Treatment Using Toshiba Heavy Ion Therapy System at East Japan Heavy Ion Center, Faculty of Medicine, Yamagata University

02/24/2021 | 06:00pm EDT

Toshiba Energy Systems & Solutions Corporation (hereinafter 'Toshiba ESS') is pleased to announce today the commencement of treatment using a heavy ion therapy* system supplied by Toshiba ESS for the East Japan Heavy Ion Center at the Faculty of Medicine, Yamagata University (hereinafter 'East Japan HIC').

Toshiba ESS has supplied a rotating gantry-type treatment room and a horizontally fixed beam treatment room, the latter of which have now begun providing treatment, while a rotating gantry** treatment room are scheduled to begin operation in summer 2021.

This system will be used to fulfill various needs, including saving energy and space, providing easy operation, and creating less waste***, as posited by East Japan HIC. By incorporating state-of-the-art technology provided by Toshiba ESS, this system is capable of three-dimensional, high-speed scanning irradiation and respiratory-gated irradiation. The company began installing the system in 2018, and after various beam adjustments and testing, treatments have now started.

Toshiba ESS developed this heavy ion therapy system through collaboration with the National Institute for Quantum and Radiological Science and Technology (QST/NIRS). In 2016, the world's first rotating gantry-type heavy ion therapy system, in which its compactness was achieved by using superconducting magnets in beam lines, was installed at QST Hospital. With the company's proven experience and technologies, this system was put forth in the international market, leading to orders from Yonsei Medical University and Seoul National University Hospital in South Korea.

Takao Konishi, Director and Senior Vice President at Toshiba ESS, said, 'Toshiba ESS is highly honored to announce the commencement of treatment using our heavy ion therapy system at East Japan HIC. Toshiba ESS will continue to contribute to the expansion of heavy ion therapy worldwide and to the realization of high quality cancer treatment.'

*A type of external radiation therapy that accelerates carbon ions to about 70% of the speed of light to form carbon ion beams (heavy particle beams) and irradiates cancer tumors from outside the body. Heavy ion beams are less likely to spread in the body and can be pinpointed to focus on cancer tumors, and are thus less likely to damage normal surrounding cells. In addition, this therapy has the advantage of having a greater capability to destroy cancer cell genes than other types of radiation, and is said to be a treatment method that enables early rehabilitation while putting less of a physical burden on the patient.

**Since the irradiation angle can be freely set at 360 degrees, cancer tumors can be irradiated from an optimum angle while the patient maintains a comfortable position. In addition, by combining the low scattering characteristics of heavy ion beams with scanning irradiation technology, it is possible to avoid the central nerves and protect organs, further enhancing the dose concentration to the cancer tumors.

***Since the compensation filter and patient collimator required in the conventional method are not required here, the treatment period can be shortened and the amount of radioactive waste can be reduced.

Information in the press releases/news, including product prices and specifications, content of services and contact information, is current on the date of the press announcement / news , but is subject to change without prior notice.

Disclaimer

Toshiba Corporation published this content on 25 February 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 March 2021 04:17:10 UTC.


© Publicnow 2021
All news about TOSHIBA CORPORATION
11:31aEXCLUSIVE : Harvard wasn't pressured over Toshiba, former Japan adviser says
RE
04:42aTOSHIBA  : board chair likely to scrape through with reappointment at crucial AG..
RE
06/21TOSHIBA  : releases internal report ahead of shareholder vote
RE
06/21TOSHIBA  : releases internal report ahead of shareholder vote
RE
06/21TOSHIBA  : Notice of Disclosure of Investigation Report Prepared by Law Firm and..
PU
06/21TOSHIBA  : Notice of Disclosure of Investigation Report Prepared by Law Firm and..
PU
06/21Japan's toshiba releases contents of feb 2021 internal probe it conducted
RE
06/21Japan's toshiba says will strive to drastically improve corporate governance
RE
06/21Japan's toshiba says sincerely accepts points made in investigation report
RE
06/20TOSHIBA  : Carrier Celebrates New China Facility Opening   (PDF)
PU
More news
Financials
Sales 2021 3 076 B 27 795 M 27 795 M
Net income 2021 84 063 M 760 M 760 M
Net Debt 2021 70 157 M 634 M 634 M
P/E ratio 2021 25,9x
Yield 2021 1,02%
Capitalization 2 185 B 19 725 M 19 746 M
EV / Sales 2021 0,73x
EV / Sales 2022 0,72x
Nbr of Employees 125 648
Free-Float 93,4%
Chart TOSHIBA CORPORATION
Duration : Period :
Toshiba Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TOSHIBA CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 4 815,00 JPY
Average target price 4 753,50 JPY
Spread / Average Target -1,28%
EPS Revisions
Managers and Directors
NameTitle
Masayoshi Hirata Chief Financial Officer & Head-Accounting
Satoshi Tsunakawa President & Chief Executive Officer
Keiichi Yumita Head-Information Systems
Yutaka Sata Vice President-Research & Development
Yoshimitsu Kobayashi Independent Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
TOSHIBA CORPORATION65.51%19 461
BERKSHIRE HATHAWAY INC.18.66%634 133
HONEYWELL INTERNATIONAL INC.1.55%150 024
SIEMENS AG16.15%129 942
GENERAL ELECTRIC COMPANY18.33%115 790
3M COMPANY11.68%113 158